4D Molecular Therapeutics, Inc. (FDMT) Financials

NASDAQ Currency in USD Disclaimer

$5.81

south_east -$0.07 (-1.19%)
Day's range
$5.7
Day's range
$5.89

FDMT Income statement / Annual

Last year (2023), 4D Molecular Therapeutics, Inc.'s total revenue was $20.72 M, an increase of 562.29% from the previous year. In 2023, 4D Molecular Therapeutics, Inc.'s net income was -$100.84 M. See 4D Molecular Therapeutics, Inc.�s key income statements, including revenue, expenses, profit, and income.

Period FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017
Period Ended 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017
Operating Revenue $20.72 M $3.13 M $18.04 M $13.61 M $6.99 M $14.13 M $5.79 M
Cost of Revenue $97.10 M $3.88 M $3.02 M $53.04 M $38.72 M $18.36 M $13.57 M
Gross Profit -$76.37 M -$751,000.00 $15.02 M -$39.43 M -$31.73 M -$4.23 M -$7.78 M
Gross Profit Ratio -3.69 -0.24 0.83 -2.9 -4.54 -0.3 -1.34
Research and Development Expenses $97.10 M $80.25 M $61.36 M $53.04 M $38.72 M $18.36 M $13.57 M
General & Administrative Expenses $36.49 M $32.91 M $28.01 M $17.24 M $13.90 M $6.17 M $3.49 M
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $36.49 M $32.91 M $28.01 M $17.24 M $13.90 M $6.17 M $3.49 M
Other Expenses $0.00 $2.54 M $16,000.00 -$181,000.00 -$46,000.00 -$2,000.00 -$40,000.00
Operating Expenses $133.59 M $113.16 M $89.37 M $70.28 M $52.61 M $24.53 M $17.06 M
Cost And Expenses $133.59 M $113.16 M $89.37 M $70.28 M $52.61 M $24.53 M $17.06 M
Interest Income $12.21 M $2.57 M $137,000.00 $152,000.00 $1.50 M $850,000.00 $89,000.00
Interest Expense $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Depreciation & Amortization $5.75 M $3.88 M $3.02 M $1.44 M $1.00 M $697,000.00 $626,000.00
EBITDA -$107.12 M -$106.15 M -$68.31 M -$55.22 M -$44.62 M -$9.70 M -$10.65 M
EBITDA Ratio -5.17 -35.17 -3.95 -4.06 -5.65 -0.69 -1.84
Operating Income Ratio -5.45 -35.17 -3.95 -4.16 -7.27 -0.74 -1.95
Total Other Income/Expenses Net $12.03 M $2.54 M $16,000.00 -$29,000.00 $1.46 M $848,000.00 $49,000.00
Income Before Tax -$100.84 M -$107.49 M -$71.32 M -$56.69 M -$49.31 M -$9.55 M -$11.22 M
Income Before Tax Ratio -4.87 -34.35 -3.95 -4.16 -7.06 -0.68 -1.94
Income Tax Expense $0.00 -$6.42 M -$3.02 M -$152,000.00 $3.63 M $848,000.00 -$89,000.00
Net Income -$100.84 M -$101.08 M -$68.30 M -$56.54 M -$52.94 M -$9.55 M -$11.22 M
Net Income Ratio -4.87 -32.3 -3.79 -4.15 -7.58 -0.68 -1.94
EPS -2.58 -3.12 -2.46 -2.12 -2 -0.76 -0.76
EPS Diluted -2.58 -3.12 -2.46 -2.12 -2 -0.76 -0.76
Weighted Average Shares Out $39.13 M $32.35 M $27.73 M $26.68 M $26.49 M $12.52 M $14.84 M
Weighted Average Shares Out Diluted $39.13 M $32.35 M $27.73 M $26.68 M $26.49 M $12.52 M $14.84 M
Link